Comparison of Hemodynamic Stability During Anesthesia Using Remimazolam and Sevoflurane in Minimally Invasive AVR
Key facts
- Who runs it
- Pusan National University Yangsan Hospital
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 64 people enrolled
- Started
- 29 Jun 2023
- Ended
- 10 Jun 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Remimazolam besylate
- Propofol/ Sevoflurane
- Record updated
- 1 August 2025
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients over 19 years old
- Patients with severe aortic stenosis, undergoing minimally invasive aortic valve replacement surgery
Who cannot take part
- Patients with known allergy to benzodiazepine, flumazenil, propofol
- Patients with hypersensitivity to Dextran40
- Patients with whom heart rate assessment is not accurate, such as atrial fibrillation
- Patients with end stage renal disease requiring hemodialysis
- Patients with history of acute angle glaucoma
- Patients with valve disease severity of grade III or higher, other than aortic valve
- Patients with galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption
- Patients who have been taking benzodiazepine for long term
- Emergency operation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Anesthetic agents can cause hypotension, and be especially dangerous in patients with severe aortic stenosis, which can lead to even circulatory collapse. Remimazolam is known for its hemodynamic stability compared to propofol. This study is designed to compare effects of remimazolam vs. sevoflurane anesthesia on intraoperative hemodynamics in patients with severe aortic valve stenosis.
The 2 groups in the trial
- RemimazolamTreatment being tested
Induction dose of 6 mg/kg/h of remimazolam with remifentanil TCI 1\~4 nanogram/mL are injected together. When patient loses consciousness, rocuronium 0.8 mg/kg is given and endotracheal intubation is performed after confirming that TOF count is less than one. Anesthesia is maintained by using remimazolam dose of 1mg/kg/h\~2mg/kg/h with remifentanil to maintain optimal depth of anesthesia, which will checked by Sedline value between 25 to 50.
Treatment: Remimazolam besylate
- Propofol/sevofluraneExisting treatment, for comparison
1% propofol 1-2mg/kg is injected with remifentanil TCI 1\~4, and when patient loses consciousness, sevoflurane is started and rocuronium 0.8mg/kg is given. After confirming that TOF count is less than one, intubation is performed and anesthesia is maintained with sevoflurane and remifentanil to keep the Sedline value between 25 and 50.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Hemodynamic Stability During Anesthesia Using Remimazolam and Sevoflurane in Patients Undergoing Minimally Invasive Aortic Valve Replacement Surgery : A Prospective Randomized Controlled Study
- Publications
- Record updated
- 1 August 2025